MARKET

VIVS

VIVS

VivoSim Labs Inc
NASDAQ
1.300
+0.010
+0.78%
After Hours: 1.320 +0.02 +1.54% 18:38 05/20 EDT
OPEN
1.270
PREV CLOSE
1.290
HIGH
1.309
LOW
1.257
VOLUME
26.37K
TURNOVER
--
52 WEEK HIGH
5.30
52 WEEK LOW
1.250
MARKET CAP
3.39M
P/E (TTM)
1.216
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VIVS last week (0511-0515)?
Weekly Report · 2d ago
Weekly Report: what happened at VIVS last week (0504-0508)?
Weekly Report · 05/11 09:15
Weekly Report: what happened at VIVS last week (0427-0501)?
Weekly Report · 05/04 09:15
VivoSim AI model predicts drug diarrhea risk with 96% accuracy using human intestinal tissues
PUBT · 04/28 12:19
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
Barchart · 04/28 07:05
Weekly Report: what happened at VIVS last week (0420-0424)?
Weekly Report · 04/27 09:15
Weekly Report: what happened at VIVS last week (0413-0417)?
Weekly Report · 04/20 09:14
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 04/17 21:05
More
About VIVS
VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company, which is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company also advances product candidates to treat inflammatory bowel disease (IBD) discovered and developed using its complex human tissue intestinal models.

Webull offers VivoSim Labs Inc stock information, including NASDAQ: VIVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIVS stock methods without spending real money on the virtual paper trading platform.